| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CSS-Mendel Institute (S.P., E.M., B.D., V.T.), 00198 Rome, Italy; Research Unit of Diabetes and Endocrine Diseases (S.P., V.T.) and Unit of Endocrinology (V.T.), CSS Scientific Institute, 71013 San Giovanni Rotondo, Italy; Department of Experimental and Clinical Medicine (D.S., F.P., F.A., G.S.), University Magna Græcia, 88100 Catanzaro, Italy; Department of Internal Medicine (M.C., R.L., N.A.) and The Center for Human Nutrition (M.C., R.L., N.A.), University of Texas Southwestern Medical Center, Dallas, Texas 75390; Research Division (Y.-Y.Z., C.P., A.D.), Joslin Diabetes Center, Boston, Massachusetts 02215; Department of Medicine (Y.-Y.Z., A.D.), Harvard Medical School, Boston, Massachusetts 02114; Departments of Clinical Sciences (E.M., V.T.) and Experimental Medicine and Pathology (B.D.), "Sapienza" University, 00161 Rome, Italy; and Department of Endocrinology and Metabolism (S.D.G., P.M.), Metabolic Unit, Ospedale Cisanello, University of Pisa, 56127 Pisa, Italy
Address all correspondence and requests for reprints to: Vincenzo Trischitta, M.D., CSS-Mendel Institute, Viale Regina Margherita 261, 00198 Rome, Italy. E-mail: vincenzo.trischitta{at}uniroma1.it.
Context: The prevalence of type 2 diabetes (T2D), particularly among young adults, has been rising steadily during the past 2 decades. T2D, especially in its early-onset subtype, is under genetic control. TRIB3 inhibits insulin-stimulated Akt phosphorylation and subsequent insulin action. A TRIB3 gain-of-function polymorphism, Q84R (rs2295490), impairs insulin signaling.
Objective: The objective of the study was to verify the association of TRIB3 Q84R with: 1) T2D, either subtyped or not according to age at diagnosis (early-onset, <45 yr, or
45 yr); 2) insulin secretion and sensitivity in nondiabetic individuals; or 3) in vitro insulin secretion from isolated human islets.
Design: Four different case-control samples comprising a total of 5469 whites were examined. Insulinogenic and insulin sensitivity indexes and their interplay (disposition index) were assessed in 645 nondiabetic individuals at oral glucose tolerance test, glucose (16.7 mmol/liter)-induced in vitro insulin secretion was assessed in islets isolated from 54 nondiabetic donors.
Results: In the whole sample, the R84 variant was nominally associated with T2D (odds ratio 1.17, 95% confidence interval 1.00–1.36, P = 0.04). When stratifying according to age of diabetes onset, R84 carriers had an increased risk of early-onset T2D (odds ratio 1.32, 95% confidence interval 1.10–1.58, P = 0.002). Among 645 nondiabetic subjects, R84 carriers had higher glucose levels (P = 0.005) and lower insulinogenic (P = 0.03) and disposition index (P = 0.02) during the oral glucose tolerance test. R84 islets were more likely to display relatively low glucose-stimulated insulin release (P = 0.04).
Conclusions: The TRIB3 R84 variant is associated with early-onset T2D in whites. Alteration in the insulin secretion/insulin sensitivity interplay appears to underlie this association.
This article has been cited by other articles:
![]() |
H.-p. Gong, Z.-h. Wang, H. Jiang, N.-n. Fang, J.-s. Li, Y.-y. Shang, Y. Zhang, M. Zhong, and W. Zhang TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis Diabetes Care, July 1, 2009; 32(7): 1311 - 1313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |